Magnetic resonance enterography in Crohn’s disease: optimal use in clinical practice and clinical trials.

References

• JPanes, YBouhnik, WReinisch, JStoker, SATaylor, DCBaumgart, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7:556–85.
   PubMed Web of Science ®Google Scholar
• JPanes, RBouzas, MChaparro, VGarcia-Sanchez, JPGisbert, BMartinez de Guerenu, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 2011;34:125–45.
   PubMed Web of Science ®Google Scholar
• IOrdas, JRimola, SRodriguez, JMParedes, MJMartinez-Perez, EBlanc, et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 2014;146:374–82; e1.
   PubMed Web of Science ®Google Scholar
• GVan Assche, KAHerrmann, ELouis, SMEverett, JFColombel, JFRahier, et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn’s disease. J Crohns Colitis 2013;7:950–7.
   PubMed Web of Science ®Google Scholar
• BPariente, JCosnes, SDanese, WJSandborn, MLewin, JGFletcher, et al. Development of the Crohn’s disease digestive damage score, the Lemann score. Inflamm Bowel Dis 2011;17:1415–22.
   PubMed Web of Science ®Google Scholar
• ANDesmond, KO’Regan, CCurran, SMcWilliams, TFitzgerald, MMMaher, et al. Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008;57:1524–9.
   PubMed Web of Science ®Google Scholar
• RSinha, RVerma, SVerma, ARajesh. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls. AJR Am J Roentgenol 2011;197:76–9.
   PubMed Web of Science ®Google Scholar
• CSSantillan. MR imaging techniques of the bowel. Magn Reson Imaging Clin N Am 2014;22:1–11.
   PubMed Web of Science ®Google Scholar
• JRimola, SRodriguez, OGarcia-Bosch, ERicart, MPages, MPellise, et al. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics 2009;29:701–19.
   PubMed Web of Science ®Google Scholar
• JRimola, WJSandborn, PHiggins, ACoimbra, TLu, PARutgeerts, et al. Feasibility, precision and reproducibility of MR enterography for detection of inflammation in Crohn’s disease in a multicenter clinical trial. Gastroenterology 2014;146:S–174.
   Web of Science ®Google Scholar
• GFiorino, CBonifacio, MPadrenostro, FMSposta, ASpinelli, AMalesci, et al. Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn’s disease. Dig Dis Sci 2013;58:3246–55.
   PubMed Web of Science ®Google Scholar
• AOussalah, VLaurent, OBruot, ABressenot, MABigard, DRegent, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010;59:1056–65.
   PubMed Web of Science ®Google Scholar
• SPunwani, MRodriguez-Justo, ABainbridge, RGreenhalgh, EDe Vita, SBloom, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009;252:712–20.
   PubMed Web of Science ®Google Scholar
• JRimola, IOrdas, SRodriguez, OGarcia-Bosch, MAceituno, JLlach, et al. Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011;17:1759–68.
   PubMed Web of Science ®Google Scholar
• JRimola, SRodriguez, OGarcia-Bosch, IOrdas, EAyala, MAceituno, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 2009;58:1113–20.
   PubMed Web of Science ®Google Scholar
• CHordonneau, ABuisson, JScanzi, FGoutorbe, BPereira, CBorderon, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol 2014;109:89–98.
   PubMed Web of Science ®Google Scholar
• JGAlbert, FMartiny, AKrummenerl, KStock, JLesske, CMGobel, et al. Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 2005;54:1721–7.
   PubMed Web of Science ®Google Scholar
• UBocker, DDinter, CLitterer, FHummel, PKnebel, AFranke, et al. Comparison of magnetic resonance imaging and video capsule enteroscopy in diagnosing small-bowel pathology: localization-dependent diagnostic yield. Scand J Gastroenterol 2010;45:490–500.
   PubMed Web of Science ®Google Scholar
• MDJensen, TNathan, SRRafaelsen, JKjeldsen. Diagnostic accuracy of capsule endoscopy for small bowel Crohn’s disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011;9:124–9.
   PubMed Web of Science ®Google Scholar
• DLNguyen, WJSandborn, EVLoftusJr, DWLarson, JGFletcher, BBecker, et al. Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn’s disease. Clin Gastroenterol Hepatol 2012;10:400–4.
   PubMed Web of Science ®Google Scholar
• ELouis, ACollard, AFOger, EDegroote, FAAboul Nasr El Yafi, JBelaiche. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777–82.
   PubMed Web of Science ®Google Scholar
• KTThia, WJSandborn, WSHarmsen, ARZinsmeister, EVLoftusJr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology 2010;139:1147–55.
   PubMed Web of Science ®Google Scholar
• CHassan, AZullo, VDe Francesco, EIerardi, MGiustini, APitidis, et al. Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther 2007;26:1457–64.
   PubMed Web of Science ®Google Scholar
• KHorsthuis, SBipat, RJBennink, JStoker. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247:64–79.
   PubMed Web of Science ®Google Scholar
• JATielbeek, MLZiech, ZLi, CLavini, SBipat, WABemelman, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol 2014;24:619–29.
   PubMed Web of Science ®Google Scholar
• MZappa, CStefanescu, DCazals-Hatem, FBretagnol, LDeschamps, AAttar, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011;17:984–93.
   PubMed Web of Science ®Google Scholar
• JRimola, MAceituno, IOrdás, AJáuregui, MGallego, SRodríguez, et al. MRI is a valuable tool for identification of fibrosis in patients with Crohn’s disease. Gastroenterology 2012;142:S22–S3.
   Web of Science ®Google Scholar
• LPeyrin-Biroulet, EVLoftusJr, JFColombel, WJSandborn. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol 2010;105:289–97.
   PubMed Web of Science ®Google Scholar
• PRutgeerts, KGeboes, GVantrappen, JBeyls, RKerremans, MHiele. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990;99:956–63.
   PubMed Web of Science ®Google Scholar
• DHBruining, HASiddiki, JGFletcher, WJTremaine, WJSandborn, EVLoftusJr. Prevalence of penetrating disease and extraintestinal manifestations of Crohn’s disease detected with CT enterography. Inflamm Bowel Dis 2008;14:1701–6.
   PubMed Web of Science ®Google Scholar
• EMessaris, NChandolias, DGrand, VPricolo. Role of magnetic resonance enterography in the management of Crohn disease. Arch Surg 2010;145:471–5.
   PubMedGoogle Scholar
• RHafeez, SPunwani, PBoulos, SBloom, SMcCartney, SHalligan, et al. Diagnostic and therapeutic impact of MR enterography in Crohn’s disease. Clin Radiol 2011;66:1148–58.
   PubMed Web of Science ®Google Scholar
• OGarcía Bosch, IOrdás, SRodríguez, AMRamírez, MAceituno, ERicart, et al. Comparison of the impact of MRI and colonoscopy on management of Crohn’s disease. Gastroenterology 2012;142:S21–S2.
   PubMed Web of Science ®Google Scholar
• RModigliani, JYMary, JFSimon, ACortot, JCSoule, JPGendre, et al. Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990;98:811–18.
   PubMed Web of Science ®Google Scholar
• JFColombel, WJSandborn, WReinisch, GJMantzaris, AKornbluth, DRachmilewitz, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 2010;362:1383–95.
   PubMed Web of Science ®Google Scholar
• KFFroslie, JJahnsen, BAMoum, MHVatn. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412–22.
   PubMed Web of Science ®Google Scholar
• FBaert, LMoortgat, GVan Assche, PCaenepeel, PVergauwe, MDe Vos, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology 2010;138:463–8; quiz e10-1.
   PubMed Web of Science ®Google Scholar
• FSchnitzler, HFidder, MFerrante, MNoman, IArijs, GVan Assche, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis 2009;15:1295–301.
   PubMed Web of Science ®Google Scholar
• LPeyrin-Biroulet, ACieza, WJSandborn, MCoenen, YChowers, THibi, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012;61:241–7.
   PubMed Web of Science ®Google Scholar
• WJSandborn, BGFeagan, SBHanauer, HLochs, RLofberg, RModigliani, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 2002;122:512–30.
   PubMed Web of Science ®Google Scholar
• JHYacoub, AOto. New magnetic resonance imaging modalities for Crohn disease. Magn Reson Imaging Clin N Am 2014;22:35–50.
   PubMed Web of Science ®Google Scholar
• JMReam, JRDillman, JAdler, SKhalatbari, JBMcHugh, PJStrouse, et al. MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol 2013;43:1077–85.
   PubMed Web of Science ®Google Scholar
• JAdler, SDSwanson, PSchmiedlin-Ren, PDHiggins, CPGolembeski, ADPolydorides, et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 2011;259:127–35.
   PubMed Web of Science ®Google Scholar
• JMFroehlich, CWaldherr, CStoupis, SMErturk, MAPatak. MR motility imaging in Crohn’s disease improves lesion detection compared with standard MR imaging. Eur Radiol 2010;20:1945–51.
   PubMed Web of Science ®Google Scholar
• AMenys, DAtkinson, FOdille, AAhmed, MNovelli, MRodriguez-Justo, et al. Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn’s disease activity: a preliminary study. Eur Radiol 2012;22:2494–501.
   PubMed Web of Science ®Google Scholar